首页> 外文期刊>Oncogenesis. >MicroRNA-34a/EGFR axis plays pivotal roles in lung tumorigenesis
【24h】

MicroRNA-34a/EGFR axis plays pivotal roles in lung tumorigenesis

机译:MicroRNA-34a / EGFR轴在肺肿瘤发生中起关键作用

获取原文
           

摘要

MicroRNAs (miRNAs) are vital in the regulation of tumor progression and invasion. Dysregulation of miRNAs has been linked to the development of various types of human cancers, including non-small-cell lung cancer (NSCLC). However, the effect of miRNA-34a (miR-34a), a key regulator of tumor suppression, on the tumorigenesis of NSCLC has not been fully elaborated. Herein, we reveal that miR-34a is significantly downregulated in NSCLC tissues and cell lines, suggesting that miR-34a might function as a tumor suppressor in lung cancer. We also confirmed that epidermal growth factor receptor (EGFR) is a direct target of miR-34a, and our data reveal that siRNA knockdown of EGFR can inhibit cell proliferation, promote apoptosis and arrest cell-cycle progression. In addition, EGFR can reverse the suppressive function of miR-34a overexpression on proliferation and cell apoptosis. Furthermore, in vivo experiments demonstrated that miR-34a suppress tumor growth, both in the A549 xenograft model, as well as in the metastatic tumors in nude mice. Taken together, our findings suggest that miR-34a inhibits NSCLC tumor growth and metastasis through targeting EGFR.
机译:MicroRNA(miRNA)在调节肿瘤的进展和侵袭中至关重要。 miRNA的失调与各种类型的人类癌症的发展有关,包括非小细胞肺癌(NSCLC)。然而,尚未充分阐明miRNA-34a(miR-34a)(一种肿瘤抑制的关键调节剂)对NSCLC肿瘤发生的作用。在本文中,我们揭示了miR-34a在NSCLC组织和细胞系中显着下调,表明miR-34a可能在肺癌中起抑癌作用。我们还证实表皮生长因子受体(EGFR)是miR-34a的直接靶标,我们的数据表明siRNA抑制EGFR可以抑制细胞增殖,促进细胞凋亡并阻止细胞周期进程。此外,EGFR可以逆转miR-34a过表达对增殖和细胞凋亡的抑制作用。此外,体内实验表明,miR-34a在A549异种移植模型以及裸鼠的转移性肿瘤中均抑制肿瘤生长。综上所述,我们的研究结果表明miR-34a通过靶向EGFR抑制NSCLC肿瘤的生长和转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号